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Abstract   
Dengue Hemorrhagic Fever (DHF) was a disease caused by dengue virus infection with high morbidity. 
Most DHF patients required hospitalization care. The length of stay of hospitalization increased the cost 
and became burden of the patient's family. Length of stay (LOS) was an indicator to assess the quality of 
health services. The purpose of this research was to analyze the factors related the LOS of pediatric 
patients with DHF in Tugurejo hospital, Semarang. This was an observational study with cross sectional 
analytic. Total sample was 137 children with DHF who was hospitalized in Tugurejo hospital, Semarang 
during the period of September 1st 2015- August 31st 2016. The sample data was obtained from medical 
records that used purposive-sampling techniques. Data analysis used chi-square test with < 0.05 
significance level and 95% confidence intervals. The analysis showed that platelet counts (p = 0.000), 
hematocrit (p = 0.000), hemoglobin (p = 0.000), complications (p = 0.000), the degree of fever (p = 
0.027) and duration of fever before hospitalization (p = 0.000) significantly related to LOS of pediatric 
patients with DHF and there was no significant related of leukocyte count (p = 0.374) to LOS of pediatric 
patients with DHF. Prolonged LOS was associated with laboratory finding and clinical manifestation. By 
knowing these factors, practitioner could provide a more effective and efficient treatment to patients 
with DHF to shorten the LOS. 
Keyword : laboratory finding, clinical manifestation, length of stay, Dengue Hemorrhagic 
Fever 
INTRODUCTION  
 
Dengue Hemorrhagic Fever (DHF) 
is a viral infection disease with rapid spread 
over the past decade.1 WHO notes that 
Indonesia is the country with the highest 
frequency of dengue fever cases in Southeast 
Asia from 1968 to 2009.2 Semarang ranks at 
third position in DHF cases after Magelang 
and Jepara in Central Java with an incidence 
rate of 98.61 per 100,000 population in 
2015.3 
Dengue virus can infect humans 
through Aedes aegypti and Aedes albopictus 
mosquitoes.1,4 Symptoms of DHF range from 
mild to severe with high mortality due to 
shock and severe haemorrhage.4 Increased 
vascular permeability, hypotension, 
decreased plasma volume, 
thrombocytopenia and bleeding disorders 
are factors that distinguish Dengue 
Hemorrhagic Fever from Dengue Fever.5 The 
diagnosis of DHF is based on clinical and 
laboratory criteria. Clinical criteria of DHF 
are high fever for 2-7, enlarged liver, at least 
one sign of bleeding such as positive Rumple 
Leed test, petechiae, ecchymosis, purpura, 
gum hemorrhage, epistaxis and 
gastrointestinal bleeding as well as the 
presence of shock that is characterized by 
rapid and weak pulse, decreased pulse 
pressure, hypotension, cold feet and hands 
with restlessness. Laboratory criteria are 
decreased platelet count ≤100.000 / μl 
(thrombocytopenia) and an increase in the 
number of hematocrit> 20% with clinical 
symptoms.6,7 
Most of DHF patients requires 
health services in specialized units equipped 
with intensive unit hospital facilities 
(ICU).1,4 Indications of hospitalization for 
DHF patients are thrombocytopenia, shock, 
increased hemoglobin, increased hematocrit, 
prolonged vomiting, seizures, consciousness 
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reduction, hematemesis and melena. And 
children becomes the most inpatient patient 
in the case of DHF.6,7 The mortality rate of 
pediatric patients with DHF who undergo 
hospitalization is 2.5% .1,4 The length of 
hospitalization is an indicator to assess the 
quality of health services. The longer 
hospitalization shows the declining quality 
of inpatient care. The shorter the 
hospitalization time indicates the good 
quality of the health service, so the patients 
get their satisfaction. The length of 
hospitalization represents the time in a 
treatment period that is calculated by the 
subtraction of the date of discharge and the 
date of admission. The longer 
hospitalization is proportional to the 
increase in the cost and burden of the 
patient's family.8,9,10 The purpose of this 
research is to analyze the factors related the 
Length of Stay (LOS) of pediatric patients 
with DHF in Tugurejo hospital, Semarang. 
 
RESEARCH METHODS  
 
                This research was analytic 
observational study with cross sectional 
approach. The sample was 137 children with 
DHF who underwent hospitalization at 
Tugurejo hospital, Semarang during period 
of September 1st 2015- August 31th 2016. 
The sample data was obtained from medical 
record using purposive-sampling technique. 
Inclusion criteria were ≤ 14 years of age 
patients diagnosed with DHF and available 
complete data on age, sex, platelet count, 
leukocyte count, hematocrit number, 
hemoglobin count, complications of bleeding 
or shock or pleural effusion, degree of fever 
and duration of fever before hospitalized. 
Exclusion criteria were DHF which was not 
the main diagnosis, the patient died and 
judicial discharge during hospitalization at 
Tugurejo hospital Semarang. Bivariate 
statistical analysis used Chi-Square with < 
0.05 significance level and 95% confidence 
intervals. 
 
 
RESULTS  
 
            Based on table 1, the sample that had 
the most characteristic value was age> 5 
years old (73%), male (54,7%) and hospital 
stay> 4 days (74,5%). The length of  stay 
ranged from 2 days to 11 days with an 
average of 5.47 days. 
 
 
Table 1. Characteristics of Age, Sex and Length of stay 
No Variable Category N Percentage 
1 Age ≤5 yo 
>5 yo 
37 
100 
27,0% 
73,0% 
2 Sex male 
female 
75 
62 
54,7% 
45,3% 
3 Length of stay 
 
≤ 4 days 
>4 days 
35 
102 
25,5% 
74,5% 
Table 2. Clinical Characteristic of patients 
No Variable Category n Percentage 
1 Thrombocyt ≤ 50.000/ µl 
> 50.000/ µl 
82 
55 
59,9% 
40,1% 
2 Leukocyte ≤ 5.000/ µl 
> 5.000/ µl 
116 
21 
84,7% 
15,3% 
3 Hematocrit < 40,7% 
≥ 40,7% 
53 
84 
38,7% 
61,3% 
4 Hemoglobin ≤ 14 g/dL 
>14 g/dL 
69 
68 
50,4% 
49,6% 
5 Complications of bleeding or 
shock or pleural effusion 
Yes 
No 
84 
53 
61,3% 
38,7% 
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6 Fever ≤ 39°C 
>39°C 
107 
30 
78,1% 
21,9% 
7 Duration of fever before 
admission 
≤3 hari 
>3 hari 
60 
77 
43,8% 
56,2% 
 
Patients with platelet counted ≤ 
50.000 / μl had a significant relations 
(p=0,000), with a chance of 0.090 times to 
have length of hospitalization> 4 days 
compared with patients with platelet 
counted > 50.000 / μl (Table 3). Patients 
with hematocrit was amount ≥ 40.7% had a 
significant relations (p=0,000), with chance 
of 20.609 times having hospitalization> 4 
days compared with patients with 
hematocrit counted <40.7%. Patients with 
hemoglobin> 14 g / dL had a significant 
relations (p=0,000), with a chance of 30.250 
having hospitalization> 4 days compared 
with patients with hemoglobin ≤ 14 g / dL. 
The number of leukocytes did not 
significantly affect the length of 
hospitalization of pediatric patients with 
DHF in Tugurejo hospital, Semarang (p = 
0.374). Complication had significantly 
affected the length of hospitalization of 
pediatric patients with DHF in Tugurejo 
hospital, Semarang (p = 0.000). The OR 
(Odds Ratio) value of 0.081 meant that 
patients with a predisposing complication of 
0.081 times had hospitalization> 4 days 
compared with patients who did not have 
complications. 
               Based on table 2, most of the 
sample had clinical characteristic in the 
form of number of platelets ≤ 50.000 / μl 
(59,9%), leukocyte count ≤ 5.000 / μl 
(84,7%), total hematocrit ≥ 40, 7% (61.3%), 
number of hemoglobin ≤ 14 g / dL (50.4%). 
Most of patients had complications (61.3%), 
fever ≤39 ° C (78.1%) and duration of fever 
> 3 days before admission (56.2%). The 
degree of fever significantly affected the 
length of hospitalization of pediatric 
patients with DHF (p = 0,027). The OR 
(Odds Ratio) value of 3,840 meant that 
patients with fever grade ≤39 ° C had a 
chance of 3,840 times having an inpatient ≤ 
4 days compared with patients with fever> 
39 ° C. The duration of fever before hospital 
admission significantly influenced the 
length of hospitalization of pediatric 
patients with DHF (p = 0,000). Value of OR 
(Odds Ratio) 0,184 meant that patient with 
fever before hospital admission ≤ 3 days 
had chance 0,184 times to get 
hospitalization> 4 days compared to patient 
who had a long duration of fever before 
hospital admission. Based on table 4, the 
results of logistic regression analysis 
showed that the number of hematocrit was 
the most influential independent variables 
on the length of hospitalization with the OR 
79.092. 
 
DISCUSSION 
Patients with lower platelet counted 
(≤ 50.000 / μl) had a longer hospital stay 
of> 4 days. The results of this study were in 
line with the results of the Ita Perwira study 
(2011) at Persahabatan Hospital, East 
Jakarta which showed that patients with 
lower platelet counted (<100.000 / μl) had 
longer hospitalization of> 5 days.11 The 
results also corresponded with research by 
Hasri Nopianto, 2012 at Dr. Kariadi 
Hospital, Semarang that showed patients 
with lower platelet counted (≤100.000 / μl) 
had a longer hospitalization time> 4 days.12 
 
The immune complex on the platelet 
surface caused platelet aggregation, then the 
platelets would be destroyed in the liver. 
Thrombocytopenia and disruption of  
trombocyte function were the main 
factors causing mild to severe hemorrhage. 
In the condition of shock which was difficult 
to overcome could be found massive 
bleeding due to thrombocytopenia and 
coagulation system disorders. Severe 
bleeding in vital organs with shock and DIC 
could risk a death. The condition required a 
rigorous evaluation in order not to fall on 
death, thus required longer hospitalization.5 
 
The results also showed that the 
leukocyte count did not significantly affect 
the length of hospitalization of pediatric 
patients with DHF in Tugurejo Hospital, 
Semarang. The results of this study did not 
in line with the results of Ita Perwira (2011) 
which indicating that patients with leukocyte 
counted <3500 / μl had LOS > 5 days.11 The 
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different outcome was probably due to the 
differences in categorization of leukocyte 
counts. In the study, the number of 
leukocytes was categorized to be <3500 / μl 
and ≥3500 / μl. Thus, the categorization of 
leukocyte counts was likely to affect the 
differences of outcome. The results of this 
study did not correspond to Hasri Nopianto 
study (2012) which showed that patients 
with higher leukocyte counts (≥5.000 / μl) 
had a shorter hospitalization time of ≤4 
days.12 The difference in outcome was 
probably due to the differences in patient 
characteristics. In the study of Hasri 
Nopianto (2012), patients with leukocyte  
<5,000 / μl was 74 patients from 122 
samples (60.7%). While in this study 
patients with leukocyte counted ≤5.000 / μl 
was 116 patients from out of total 137 
children (84.7%). The condition showed that 
the majority of patients had a leukocyte 
count of ≤5.000 / μl. Thus, the characteristic 
of differences had the possibility of 
influencing outcomes. Leukocyte was one of 
the laboratory values that played role in the 
process of host immunity. Leukopenia or 
decreased number of leukocytes could occur 
due to the decline in the number of 
granulocyte cells such as neutrophil cells. 13 
 
Table 3. Relations Between Laboratory Finding And Clinical Characteristic And 
Length Of Stay Patient Of DHF 
  Lenght Of Stay p value OR 95%CI 
 ≤ 4 
days 
> 4 
days 
  
Trombocyte ≤ 50.000/ µl 7 75 0,000 0,090 0,035-0,230 
 > 50.000/ µl 28 27    
Leukocyte ≤ 5.000/ µl 28 88 0,374 0,636 0,234-1,733 
> 5.000/ µl 7 14    
Hematocrit < 40,7% 30 23 0,000 20,609 7,179 - 59,159 
≥ 40,7% 5 79    
Hemoglobin ≤ 14 g/dL 33 36 0,000 30,250 6,859-133,41 
>14 g/dL 2 66    
Complications of 
bleeding or shock or 
pleural effusion 
Yes 7 77 0,000 0,081 0,032-0,208 
 No 28 25    
Fever ≤ 39°C 32 75 0,027 3,840 1,086-13,572 
>39°C 3 27    
Duration of fever 
before admission 
≤3 days 6 54 0,000 0,184 0,070-0,481 
>3 days 29 48    
              
Patients with higher hematocrit (≥ 
40.7%) had a longer hospital stay of> 4 days. 
The results of this study were not in 
accordance with the research of Hasri 
Nopianto (2012) which showed that the 
number of hematocrit did not affect the 
length of hospitalization of patients with 
dengue infection in Dr Kariadi Hospital, 
Semarang.14 The differences results might be 
caused by the differences in the 
categorization of hematocrit and sample. In 
that study, the number of hematocrits was 
categorized to <35% and ≥ 35% with adult 
sample. In this study, the number of 
hematocrits was categorized into <40.7% 
and ≥ 40.7% with a sample of patients aged 
≤ 14 years. Thus, the differences in 
categorization of variables had the 
possibility of influencing outcomes. Patients 
with higher hemoglobin (> 14 g / dL) had a 
longer hospital stay of> 4 days. 
Hematocrit and hemoglobin were the values 
that could describe the condition of hemo-
concentration. Plasma leakage to the 
extravascular through damaged blood 
vessels could result in shock. Under these 
conditions, the hematocrit and hemoglobin 
values would increase according to the 
degree of plasma leakage. Patients with 
shock required a rigorous evaluation to 
avoid a poor prognosis, so the time taken for 
hospitalization would be longer. However, 
hematocrit values were more sensitive in 
assessing hemo-concentration compared to 
hemoglobin values. The value of hemoglobin 
could be used in assessing hemo-
concentration if there was no result of 
hematocrit value.5 
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Patients with complications of 
bleeding or shock or pleural effusion had a 
longer hospital stay (> 4 days). The results of 
this study were in accordance with Ita 
Perwira study (2011), indicating that 
patients with complications had a long 
hospitalization (> 5 days).11 That 
complications could occur during 
hospitalization. Patients with complications 
required more rigorous evaluation than 
patients without complications. 
Management of shock should be done 
adequately because it could worsen into a 
severe shock (profound shock). Severe 
bleeding in vital organs accompanied by 
shock and DIC caused death. These 
conditions required intensive supervision to 
avoid a poor prognosis such as death, so the 
patients needed longer hospitalization.5 
Patients with a fever of > 39 ° C had 
a longer hospital stay (>4 days). Increased 
body temperature during infection might 
reflect pathogenic replication. In the Jih-Jin 
Tsai study (2013) proved that the body 
temperature was associated with viremia. 
The higher of body temperature the higher 
of number of viruses in the body.14 Based on 
the research of Annette Fox et al (2011) and 
Yang Bo Tang et al (2010) showed that the 
viremia affected the severity of dengue 
infection.15,16 Patients with high viremia 
affected the severity of disease, then 
requiring adequate management and longer 
hospitalization time. 
Patients with long fever prior to 
admission Hospital ≤ 3 days had longer 
hospitalization (> 4 days). The results of this 
study were in accordance with Ita Perwira 
study, 2011 at Persahabatan Hospital, East 
Jakarta which showed that patients with 
long fever prior to hospital admission had 
longer hospitalization length which was 
more than > 5 days.11 The length of fever 
before hospital admission was associated 
with the tendency of parents in seeking 
treatment to the hospital. The higher body 
temperature and the duration of fever, 
parent would be more worried and 
immediately seek a treatment. The higher 
temperature indicated the higher amount of 
virus in the blood or viremia. 
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